Vera Therapeutics (VERA) Equity Income (2021 - 2024)
Vera Therapeutics (VERA) reported Equity Income of -$7000.0 for Q2 2024, up 75.0% on a YoY basis from -$4000.0 in Q3 2023, and down 75.0% quarter-over-quarter from -$4000.0 in Q1 2024.
Vera Therapeutics (VERA) Equity Income (2021 - 2024) Analysis & Trends
Vera Therapeutics has reported Equity Income for 4 years, with the latest figure at -$7000.0 in Q2 2024.
- For the quarter ending Q2 2024, Equity Income rose 75.0% year-over-year to -$7000.0; the trailing twelve-month figure through Jun 2024 stood at -$28000.0 (up 90.51% YoY), and the FY2023 full-year result was -$47000.0, up 94.19% from the prior year.
- Equity Income for Q2 2024 stood at -$7000.0, down from -$4000.0 in the prior quarter.
- The five-year high for Equity Income was -$1000.0 in Q1 2023, with the low at -$364000.0 in Q3 2021.
- Historically, Equity Income has averaged -$135230.8 across 4 years, with a median of -$64000.0 in 2022.
- Annual changes were most pronounced in 2023 — Equity Income soared 99.65% — and 2024, when it sank 300.0%.
- Vera Therapeutics' Equity Income stood at -$247000.0 in 2021, then surged by 74.09% to -$64000.0 in 2022, then jumped by 96.88% to -$2000.0 in 2023, then tumbled by 250.0% to -$7000.0 in 2024.
- The last three Equity Income figures came in at -$7000.0 (Q2 2024), -$4000.0 (Q1 2024), and -$2000.0 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 235,807.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Vera Therapeutics | 2.51 Bn | 1.91 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -7,000.00 |
| Mar 31, 2024 | -4,000.00 |
| Dec 31, 2023 | -2,000.00 |
| Sep 30, 2023 | -15,000.00 |
| Jun 30, 2023 | -28,000.00 |
| Mar 31, 2023 | -1,000.00 |
| Dec 31, 2022 | -64,000.00 |
| Sep 30, 2022 | -202,000.00 |
| Jun 30, 2022 | -256,000.00 |
| Mar 31, 2022 | -287,000.00 |
| Dec 31, 2021 | -247,000.00 |
| Sep 30, 2021 | -364,000.00 |
| Jun 30, 2021 | -281,000.00 |